Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomised Multicenter Study for Therapy Optimization (First Line) of Advanced Progredient, Low Malignant Non-Hodgkin Lymphomas and Mantle Cell Lymphomas

NCT00991211 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT00991211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00991211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomised Multicenter Study for Therapy Optimization (First Line) of Advanced Progredient, Low Malignant Non-Hodgkin Lymphomas and Mantle Cell Lymphomas
Lead sponsor
University of Giessen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
August 31, 2009
Enrollment
549 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphomas, immunocytomas, lymphocytic lymphomas, marginal zone lymphomas, non-hodgkin lymphomas